Janney Montgomery Scott LLC Purchases 13,586 Shares of Enovis Co. (NYSE:ENOV)

Janney Montgomery Scott LLC increased its position in shares of Enovis Co. (NYSE:ENOV - Free Report) by 198.9% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 20,416 shares of the company's stock after acquiring an additional 13,586 shares during the period. Janney Montgomery Scott LLC's holdings in Enovis were worth $896,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. UMB Bank n.a. grew its stake in shares of Enovis by 128.2% in the fourth quarter. UMB Bank n.a. now owns 778 shares of the company's stock worth $34,000 after purchasing an additional 437 shares during the last quarter. Pinnacle Bancorp Inc. lifted its holdings in Enovis by 54.5% during the 4th quarter. Pinnacle Bancorp Inc. now owns 850 shares of the company's stock worth $37,000 after buying an additional 300 shares during the period. DekaBank Deutsche Girozentrale bought a new stake in shares of Enovis in the 3rd quarter valued at about $55,000. FMR LLC increased its stake in shares of Enovis by 20.5% in the third quarter. FMR LLC now owns 2,840 shares of the company's stock valued at $122,000 after buying an additional 484 shares during the period. Finally, Heritage Family Offices LLP bought a new position in shares of Enovis during the third quarter worth about $206,000. Institutional investors own 98.45% of the company's stock.

Wall Street Analyst Weigh In

Separately, Needham & Company LLC reiterated a "buy" rating and issued a $65.00 target price on shares of Enovis in a report on Thursday, November 7th. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $65.86.

Enovis Trading Up 1.0 %

Shares of Enovis stock traded up $0.45 on Monday, hitting $44.45. 670,524 shares of the company's stock traded hands, compared to its average volume of 1,111,005. The company has a fifty day moving average of $45.82 and a two-hundred day moving average of $44.48. Enovis Co. has a one year low of $38.27 and a one year high of $65.03. The company has a market capitalization of $2.53 billion, a price-to-earnings ratio of -20.30 and a beta of 1.94. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.27 and a quick ratio of 1.12.

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.